Related references
Note: Only part of the references are listed.Bispecific T-cells Expressing Polyclonal Repertoire of Endogenous γδ T-cell Receptors and Introduced CD19-specific Chimeric Antigen Receptor
Drew C. Deniger et al.
MOLECULAR THERAPY (2013)
Immunotherapy of cancer in 2012
John M. Kirkwood et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2012)
IL-21 enhances the potential of human γδ T cells to provide B-cell help
Raj R. Bansal et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2012)
IL-21 Regulates the Differentiation of a Human γδ T Cell Subset Equipped with B Cell Helper Activity
Nadia Caccamo et al.
PLOS ONE (2012)
Harnessing γδ T cells in anticancer immunotherapy
Dalil Hannani et al.
TRENDS IN IMMUNOLOGY (2012)
Differentiation, phenotype, and function of interleukin-17-producing human Vγ9Vδ2 T cells
Nadia Caccamo et al.
BLOOD (2011)
Combination of IFNγ and Chemotherapeutic Agents Increase TRAIL Sensitivity of Neuroblastoma Cell Lines
H. X. Tong et al.
EUROPEAN JOURNAL OF PEDIATRIC SURGERY (2011)
Contribution of IL-17-producing γδ T cells to the efficacy of anticancer chemotherapy
Yuting Ma et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2011)
Epidermal Growth Factor Receptor Expression Identifies Functionally and Molecularly Distinct Tumor-Initiating Cells in Human Glioblastoma Multiforme and Is Required for Gliomagenesis
Stefania Mazzoleni et al.
CANCER RESEARCH (2010)
Partial and Ineffective Activation of Vγ9Vδ2 T Cells by Mycobacterium tuberculosis-Infected Dendritic Cells
Serena Meraviglia et al.
JOURNAL OF IMMUNOLOGY (2010)
Cancer stem cells at the crossroads of current cancer therapy failures Radiation oncology perspective
Ulrike Koch et al.
SEMINARS IN CANCER BIOLOGY (2010)
γδ T cell effector functions: a blend of innate programming and acquired plasticity
Marc Bonneville et al.
NATURE REVIEWS IMMUNOLOGY (2010)
Efficient Killing of Human Colon Cancer Stem Cells by gamma delta T Lymphocytes
Matilde Todaro et al.
JOURNAL OF IMMUNOLOGY (2009)
A Rapid Crosstalk of Human γδ T Cells and Monocytes Drives the Acute Inflammation in Bacterial Infections
Matthias Eberl et al.
PLOS PATHOGENS (2009)
Cancer stem cells - old concepts, new insights
L. Vermeulen et al.
CELL DEATH AND DIFFERENTIATION (2008)
Dysregulation of the host mevalonate pathway during early bacterial infection activates human TCR γδ cells
Magdalena Kistowska et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2008)
Exploring the role of cancer stem cells in radioresistance
Michael Baumann et al.
NATURE REVIEWS CANCER (2008)
Low concentrations of doxorubicin sensitizes human solid cancer cells to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-receptor (R) 2-mediated apoptosis by inducing TRAIL-R2 expression
Xiu-Xian Wu et al.
CANCER SCIENCE (2007)
Colon cancer stem cells dictate tumor growth and resist cell death by production of interleukin-4
Matilde Todaro et al.
CELL STEM CELL (2007)
Lysis of a broad range of epithelial tumour cells by human γδ T cells:: Involvement of NK62D ligands and T-cell receptor- versus NKG2D-dependent recognition
P. Wrobel et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2007)
Chemotherapy and zoledronate sensitize solid tumour cells to Vγ9Vδ2 T cell cytotoxicity
Stephen R. Mattarollo et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2007)
Bisphosphonates target multiple sites in both cis- and trans-prenyltransferases
Rey-Ting Guo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Distinct cytokine-driven responses of activated blood γδ T cells:: Insights into unconventional T cell pleiotropy
David Vermijlen et al.
JOURNAL OF IMMUNOLOGY (2007)
CXCR5 identifies a subset of Vγ9Vδ2 T cells which secrete IL-4 and IL-10 and help B cells for antibody production
Nadia Caccamo et al.
JOURNAL OF IMMUNOLOGY (2006)
Chemotherapy pretreatment sensitizes solid tumor-derived cell lines to Vα24+ NKT cell-mediated cytotoxicity
Stephen R. Mattarollo et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
Type, density, and location of immune cells within human colorectal tumors predict clinical outcome
Jerom Galon et al.
SCIENCE (2006)
Vγ9Vδ2 T cell response to colon carcinoma cells
M Corvaisier et al.
JOURNAL OF IMMUNOLOGY (2005)
Subtoxic concentration of doxorubicin enhances TRAIL-induced apoptosis in human prostate cancer cell line LNCaP
J Kang et al.
PROSTATE CANCER AND PROSTATIC DISEASES (2005)
Phase III randomized multicenter study of a humanized anti-CD33 monoclonal antibody, lintuzumab, in combination with chemotherapy, versus chemotherapy alone in patients with refractory or first-relapsed acute myeloid leukemia
EJ Feldman et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Opinion - Immunotherapy and chemotherapy - a practical partnership
RA Lake et al.
NATURE REVIEWS CANCER (2005)
Sequential application of chemotherapy and monoclonal CD 20 antibody: Successful treatment of advanced composite-lymphoma
D Linck et al.
LEUKEMIA & LYMPHOMA (2005)
Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma
R Galli et al.
CANCER RESEARCH (2004)
Microbial isoprenoid biosynthesis and human γδ T cell activation
M Eberl et al.
FEBS LETTERS (2003)
Human T cell receptor γδ cells recognize endogenous mevalonate metabolites in tumor cells
HJ Gober et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
TRAIL/Apo2L ligands induce apoptosis in malignant rhabdoid tumor cell lines
S Yoshida et al.
PEDIATRIC RESEARCH (2003)
Chemotherapeutic agents sensitize osteogenic sarcoma cells, but not normal human bone cells, to Apo2L/TRIAL-induced apoptosis
A Evdokiou et al.
INTERNATIONAL JOURNAL OF CANCER (2002)
Differentiation of resting human peripheral blood γδ T cells toward Th1-or Th2-phenotype
D Wesch et al.
CELLULAR IMMUNOLOGY (2001)
Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.
DJ Slamon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Share Paper
